Seeing Is Believing
Currently out of the existing stock ratings of Andrew Galler, 12 are a BUY (60%), 2 are a SELL (10%), 6 are a HOLD (30%).
Analyst Andrew Galler works with a stock forecast success ratio of 75% fulfilled within 223 days on average.
Andrew Galler’s has documented 44 price targets and ratings displayed on 6 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on FOLD, Amicus Therapeutics at 09-Nov-2023.
Analyst best performing recommendations are on ARWR (ARROWHEAD PHARMACEUTICALS).
The best stock recommendation documented was for ARWR (ARROWHEAD PHARMACEUTICALS) at 11/29/2022. The price target of $37 was fulfilled within 22 days with a profit of $7.01 (23.37%) receiving and performance score of 10.62.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
19
$8.57 (82.17%)
19
1 months 15 days ago
6/13 (46.15%)
$7.42 (64.08%)
454
Buy
22
$11.57 (110.93%)
2 months 4 days ago
0/4 (0%)
$9.18 (71.61%)
Hold
15
$4.57 (43.82%)
14
5 months 24 days ago
2/5 (40%)
$5.02 (50.30%)
275
Buy
18
$7.57 (72.58%)
14
7 months 5 days ago
2/4 (50%)
$6.14 (51.77%)
405
Buy
16
$5.57 (53.40%)
17
1 years 9 days ago
2/6 (33.33%)
$4.51 (39.25%)
578
Which stock is Andrew Galler is most bullish on?
What Year was the first public recommendation made by Andrew Galler?